BnR Summit 2026

Belt & Road Summit - Deal-Making 2026

9 – 15 Sept 2026 | Hong Kong, China (Hong Kong)

Register
Register
Register

ProjectUpdated on 11 August 2026

EveryBaby: AI-enabled handheld device for preterm birth prediction, raising Seed to accelerate Asia clinical rollout

CEO at EveryBaby

China (Hong Kong)

About

Preterm birth: leading cause of neonatal death, ~15M births/year globally (WHO).

EveryBaby's handheld device measures cervical electrical impedance at the point of care and returns a risk score in seconds. No lab required.

Status

- UAE: Conditional Approval (DoH Abu Dhabi). PIVOTAL study Q1 2027.

- IP Protected

- Manufacturing: Tier 1 assembly partner secured.

Seeking: Seed investors, hospital networks, and distributors across GCC, ASEAN, and Greater China.

Project Location

  • China (Hong Kong)

Project Website

https://www.every-baby.com/

Project Format

  • Private Project

Go Global Project

  • Yes

ESG (Environmental, Social, and Governance)

  • Yes

Project Stage

  • Feasibility Study Completed

Main Project Sector

  • Technology

Technology

  • Medical Technology

Investment Capital Required

  • 2,500,001 to 5,000,000 USD

Interested Format of Cooperation

  • Open for Negotiation

Preferred Financing Model

  • Open for negotiation

Type(s) of Last Financing Round of the project (if Applicable)

  • Equity (private)

Main Service(s) Required

  • Financial Services

Financial Services

  • Institutional Investment
  • Islamic Finance
  • Private Equity & Venture Capital

Organisation

EveryBaby

China (Hong Kong)

Similar opportunities